April 20 (Reuters) - Pharmather Holdings Ltd PHRM.CD :
* PHARMATHER ANNOUNCES SUBMISSION OF IND APPLICATION WITH THE FDA FOR PHASE 2 CLINICAL TRIAL EVALUATING KETAMINE IN THE TREATMENT OF PARKINSON'S DISEASE
April 20 (Reuters) - Pharmather Holdings Ltd PHRM.CD :
* PHARMATHER ANNOUNCES SUBMISSION OF IND APPLICATION WITH THE FDA FOR PHASE 2 CLINICAL TRIAL EVALUATING KETAMINE IN THE TREATMENT OF PARKINSON'S DISEASE